Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400084156Phase 4Not yet recruiting
Phase 4, randomised trial in knee osteoarthritis (OA) comparing Sufentanil arm with Oxycodone arm (2 arms). Primary endpoint: Incidence of chronic pain 6 months after surgery. Planned start May 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400084156.